Please login to the form below

Living with RA Report

Living with Rheumatoid Arthritis 2016 is a new syndicated report which offers low-cost, high-value quantitative insight into patient attitudes and behaviour.

RA is a progressive and debilitating disease which affects around 3m people in Europe. The RA market is about to undergo significant changes in the next few years as newer entrants with novel modes of action complete with established brands, and biosimilars become accepted for use as cheaper alternatives to the branded biologics.

The full PowerPoint report, which includes a patient segmentation analysis, will be available early March 2016.

Find out more:
http://www.researchpartnership.com/what-we-do/syndicated/-reports/living-with-ra-report/?utm_source=...


3rd March 2016

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

Making sense of Nutraceuticals in China
Published in eyeforpharma February 2017 by Marc Yates
Research Partnership
Research Partnership has been ranked in the Pharma Times Pharma Fast 50

Research Partnership
Women's health in emerging markets

Research Partnership
Research Partnership has published a new Living with Lupus (SLE) market report for 2017
SLE is a progressive and debilitating disease which affects 5 million people worldwide.
Research Partnership
Cool heads in a crisis?
Understanding the role pharmaceutical companies can play in fighting today’s global health pandemics
Research Partnership
Biosimilars: Bringing patients into the conversation
Published in eyeforpharma January 2017 by Mariel Metcalfe
Research Partnership